Reuters logo
3 years ago
BRIEF-PledPharma says futility analysis in PLIANT study completed and approved by the DSMB
August 18, 2014 / 6:41 AM / 3 years ago

BRIEF-PledPharma says futility analysis in PLIANT study completed and approved by the DSMB

1 Min Read

Aug 18 (Reuters) - PledPharma publ AB : * Says futility analysis in PLIANT study completed and approved by the DSMB * Says analysis covers first 30 patients in study who have completed 4

treatment cycles with chemotherapy mixture FOLFOX * Source text for Eikon * Further company coverage

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below